These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 3548266

  • 21. Analysis of mortality in pergolide-treated patients with Parkinson's disease.
    Sayler ME, Street JS, Bosomworth JC, Potvin JH, Kotsanos JG.
    Neuroepidemiology; 1996; 15(1):26-32. PubMed ID: 8719046
    [Abstract] [Full Text] [Related]

  • 22. Treatment of early Parkinson's disease: are complicated strategies justified?
    Ahlskog JE.
    Mayo Clin Proc; 1996 Jul; 71(7):659-70. PubMed ID: 8656708
    [Abstract] [Full Text] [Related]

  • 23. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 24. One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
    Diamond SG, Markham CH.
    Adv Neurol; 1984 Apr; 40():537-9. PubMed ID: 6695633
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study.
    Sage JI, Mark MH.
    Clin Neuropharmacol; 1988 Apr; 11(2):174-9. PubMed ID: 3378226
    [No Abstract] [Full Text] [Related]

  • 27. Double-blind trial of pergolide for Parkinson's disease.
    Diamond SG, Markham CH, Treciokas LJ.
    Neurology; 1985 Mar; 35(3):291-5. PubMed ID: 3883232
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Pergolide: a useful agonist for the treatment of Parkinson disease].
    Bonnet AM, Houeto JL.
    Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
    [Abstract] [Full Text] [Related]

  • 30. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH, Odin P.
    Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
    Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D.
    Neurology; 1988 Jul; 38(7):1143-6. PubMed ID: 3290706
    [Abstract] [Full Text] [Related]

  • 33. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
    Gilligan B, Wodak J, Stark R, O'Halloran M.
    Med J Aust; 1979 Aug 25; 2(4):205-7. PubMed ID: 390336
    [Abstract] [Full Text] [Related]

  • 34. Parkinson's disease: Cogentin with Sinemet, a better response.
    Tourtellotte WW, Potvin AR, Syndulko K, Hirsch SB, Gilden ER, Potvin JH, Hansch EC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Aug 25; 6(1):51-5. PubMed ID: 7202230
    [Abstract] [Full Text] [Related]

  • 35. A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
    Diamond SG, Markham CH, Treciokas LJ.
    Ann Neurol; 1978 Mar 25; 3(3):267-72. PubMed ID: 352236
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
    Bara-Jimenez W, Dimitrova T, Sherzai A, Favit A, Mouradian MM, Chase TN.
    Mov Disord; 2004 Oct 25; 19(10):1183-6. PubMed ID: 15390018
    [Abstract] [Full Text] [Related]

  • 39. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
    García de Yébenes J, Mateo D, Pino MA, Cordero M, Pastor M, Chacón J, Morales B, Sánchez V, Mena MA, Giménez Roldán S.
    Neurologia; 1997 Apr 25; 12(4):145-56. PubMed ID: 9235023
    [Abstract] [Full Text] [Related]

  • 40. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Bonnet AM, Serre I, Marconi R, Agid Y, Dubois B.
    Mov Disord; 1995 Sep 25; 10(5):668-71. PubMed ID: 8552122
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.